Wed, Aug 27, 2014, 7:05 AM EDT - U.S. Markets open in 2 hrs 25 mins

Recent

% | $
Quotes you view appear here for quick access.

Aegerion Pharmaceuticals, Inc. (AEGR) Message Board

  • censored53 censored53 Jul 30, 2013 9:05 AM Flag

    AEGR Con Continues....

     

    at this point they need BS (and accounting shell games) to justify springing their trap....

    their pre-market MARKET CAP built on price fixing and BS is 2,500 million

    "Net product sales for the second-quarter ended June 30, 2013 were $6.5 million. For the first six months of 2013, net product sales totaled $7.7 million.

    For the second-quarter ended June 30, 2013, net loss was $18.9 million, or $0.66 per share, compared with a net loss of $13.9 million, or $0.63 per share, for the same period in 2012. For the six months ended June 30, 2013, net loss was $37.0 million, or $1.30 per share, compared with a net loss of $25.6 million, or $1.18 per share, for the same period in 2012."

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • system_architect_enterprise system_architect_enterprise Jul 30, 2013 9:24 AM Flag

      Your lack of foresight blinds you. You can justify your investment decisions however you wish, but it is all about the future.

      It isn't price fixing, it isn't collusion, it isn't crooked, it is simply good business.

      If you only look at the current value without any eye towards the future, that explains your losses.
      I firmly believe that you won't admit you were wrong even when AEGR has 5,000 patients on their medication, all paid by insurance, and you will still claim it is a "scam" when in fact, it was simply your inability to see the potential.

 
AEGR
30.97+0.15(+0.49%)Aug 26 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.